Literature DB >> 24577065

A multisite randomized controlled trial on time to self-support among sickness absence beneficiaries. The Danish national return-to-work programme.

Maj Britt D Nielsen1, Jørgen Vinsløv Hansen2, Birgit Aust2, Torill Tverborgvik3, Birthe L Thomsen2, Jakob Bue Bjorner4, Ole Steen Mortensen5, Reiner Rugulies6, Glen Winzor2, Palle Ørbæk7, Trine Helverskov2, Nicolai Kristensen8, Otto Melchior Poulsen2.   

Abstract

BACKGROUND: In 2010, the Danish Government launched the Danish national return-to-work (RTW) programme to reduce sickness absence and promote labour market attainment. Multidisciplinary teams delivered the RTW programme, which comprised a coordinated, tailored and multidisciplinary effort (CTM) for sickness absence beneficiaries at high risk for exclusion from the labour market. The aim of this article was to evaluate the effectiveness of the RTW programme on self-support.
METHODS: Beneficiaries from three municipalities (denoted M1, M2 and M3) participated in a randomized controlled trial. We randomly assigned beneficiaries to CTM (M1: n = 598; M2: n = 459; M3: n = 331) or to ordinary sickness absence management (OSM) (M1: n = 393; M2: n = 324; M3: n = 95). We used the Cox proportional hazards model to estimate hazard ratios (HR) comparing rates of becoming self-supporting between beneficiaries receiving CTM and OSM.
RESULTS: In M2, beneficiaries from employment receiving CTM became self-supporting faster compared with beneficiaries receiving OSM (HR = 1.32, 95% CI: 1.08-1.61). In M3, beneficiaries receiving CTM became self-supporting slower than beneficiaries receiving OSM (HR = 0.72, 95% CI: 0.54-0.95). In M1, we found no difference between the two groups (HR = 0.99, 95% CI: 0.84-1.17).
CONCLUSION: The effect of the CTM programme on return to self-support differed substantially across the three participating municipalities. Thus, generalizing the study results to other Danish municipalities is not warranted. TRIAL REGISTRATION: ISRCTN43004323.
© The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24577065     DOI: 10.1093/eurpub/cku016

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  6 in total

1.  Neck-Shoulder Pain and Work Status among Former Sewing Machine Operators: A 14-year Follow-up Study.

Authors:  Emma Lise Thorlund Jakobsen; Karin Biering; Anette Kærgaard; Johan Hviid Andersen
Journal:  J Occup Rehabil       Date:  2018-03

2.  Effects of a randomized controlled intervention trial on return to work and health care utilization after long-term sickness absence.

Authors:  Anne-Mette H Momsen; Christina Malmose Stapelfeldt; Claus Vinther Nielsen; Maj Britt D Nielsen; Birgit Aust; Reiner Rugulies; Chris Jensen
Journal:  BMC Public Health       Date:  2016-11-09       Impact factor: 3.295

3.  Return to Work after a Stroke in Working Age Persons; A Six-Year Follow Up.

Authors:  Emma Westerlind; Hanna C Persson; Katharina S Sunnerhagen
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

4.  Improving the effectiveness of sickness benefit case management through a public-private partnership? A difference-in-difference analysis in eighteen Danish municipalities.

Authors:  Malene Rode Larsen; Birgit Aust; Jan Høgelund
Journal:  BMC Public Health       Date:  2017-04-18       Impact factor: 3.295

5.  Municipal return to work management in cancer survivors undergoing cancer treatment: a protocol on a controlled intervention study.

Authors:  Christina M Stapelfeldt; Merete Labriola; Anders Bonde Jensen; Niels Trolle Andersen; Anne-Mette H Momsen; Claus Vinther Nielsen
Journal:  BMC Public Health       Date:  2015-07-29       Impact factor: 3.295

6.  Implementation of a disability management policy in a large healthcare employer: a quasi-experimental, mixed-methods evaluation.

Authors:  Cameron A Mustard; Kathryn Skivington; Morgan Lay; Marni Lifshen; Jacob Etches; Andrea Chambers
Journal:  BMJ Open       Date:  2017-06-17       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.